Caspi_sup2+spii_sup signalling in damaged endothelium: Do connexin hemichannels aid in filling the gap?

Current Drug Therapy

Volumn 5, Issue 4, 2010, Pages 277-287

  Moccia, Francesco ^a   Avelino Cruz, José Everardo ^a   Sánchez Hernández, Yuly ^a   Tanzi, Franco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Ca2+ entry; Cardiovascular disorders; Connexin hemichannels; Drug eluting stents; Endothelial injury; Rat aorta

Indexed keywords

CATION CHANNEL; G PROTEIN COUPLED RECEPTOR; GAP JUNCTION PROTEIN; HEPTANOL; TYROSINE KINASE RECEPTOR;

ANGIOPLASTY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL ACTIVATION; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXTRACELLULAR CALCIUM; HUMAN; IN VITRO STUDY; IN-STENT RESTENOSIS; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WOUND HEALING;

EID: 78649299007     PISSN: 15748855     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488510792927483     Document Type: Article

References (130)

1. Michiels C. Endothelial cell functions. J Cell Physiol 2003; 196: 430-43.
2. Tesfamariam B, DeFelice AF. Endothelial injury in the initiation and progression of vascular disorders. Vasc Pharmacol 2007; 46: 229-37.
3. Munaron L. Intracellular calcium, endothelial cells and angiogenesis. Recent Pat Anticancer Drug Discov 2006; 1: 105-19.
4. 2+ signaling, TRP channels, and endothelial permeability. Microcirculation 2006; 13: 693-708.
5. Kuruvilla L, Kartha CC. Molecular mechanisms in endothelial regulation of cardiac function. Mol Biol Cell 2003; 253: 113-23.
6. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardeña G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 2000; 902: 230-9.
7. Zargham R. Preventing restenosis after angioplasty: a multistage approach. Clin Sci 2008; 114: 257-64.
8. Vanhoutte PM. Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J 2009; 73: 595-601.
9. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 2009; 196: 193-222.
10. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115: 1285-95.
11. Khazaei M, Moien-Afshari F, Laher I. Vascular endothelial function in health and diseases. Pathophysiology 2008; 15: 49-67.
12. Watt J, Wadsworth R, Kennedy S, Oldroyd KG. Pro-healing drugeluting stents: a role for antioxidants? Clin Sci 2008; 114: 265-73.
13. Nesbitt WS, Mangin P, Salem HH, Jackson SP. The impact of blood rheology on the molecular and cellular events underlying arterial thrombosis. J Mol Med 2006; 84: 989-95.
14. Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27: 1500-10.
15. Celik T, Iyisoy A, Kursaklioglu H, Celik M. The forgotten player of in-stent restenosis: endothelial dysfunction. Int J Cardiol 2008; 126: 443-4.
16. Hou CJ, Tsai CH, Yeh HI. Endothelial connexins are downregulated by atherogenic factors. Front Biosci 2008; 13: 3549-57.
17. Tada T, Reidy MA. Endothelial regeneration. IX. Arterial injury followed by rapid endothelial repair induces smooth-muscle-cell proliferation but not intimal thickening. Am J Pathol 1987; 129: 429-33.
18. Coomber BL, Gotlieb AI. In vitro endothelial wound repair. Interaction of cell migration and proliferation. Arteriosclerosis 1990; 10: 215-22.
19. 2+ signals and pre-wound serum signals is required for proliferation after mechanical injury. Cell Prolif 1998; 31: 155-70.
20. 2+]i increase and its transcriptional activation of immediate early genes is important in the regulation of motility. Exp Cell Res 1999; 246: 319-26.
21. Unger GM, Bellrichard RL, Trinh BI, Sammak PJ. Quantitative assessment of leading edge adhesion: reattachment kinetics modulated by injury-derived intracellular calcium predict wound closure rates in endothelial monolayers. J Cell Physiol 1998; 174: 217-31.
22. 2+ signaling and re-endothelialization. J Cell Physiol 2008; 214: 595-603.
23. Pompilio G, Capogrossi MC, Pesce M, et al. Endothelial progenitor cells and cardiovascular homeostasis: clinical implications. Int J Cardiol 2009; 131: 156-67.
24. Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, Trebak M. Stim1 and Orai1 mediate CRAC currents and storeoperated calcium entry important for endothelial cell proliferation. Circ Res 2008; 103: 1289-99.
25. Ariyoshi H, Yoshikawa N, Aono Y, et al. Localized activation of m-calpain in migrating human umbilical vein endothelial cells stimulated by shear stress. J Cell Biochem 2001; 81: 184-92.
26. Chaudhuri P, Colles SM, Bhat M, Van Wagoner DR, Birnbaumer L, Graham LM. Elucidation of a TRPC6-TRPC5 channel cascade that restricts endothelial cell movement. Mol Biol Cell 2008; 19: 3203-11.
27. 2+-signaling enhances rat gastric microvascular endothelial cell migration. J Physiol Pharmacol 2000; 51: 799-811.
28. Hamdollah Zadeh MA, Glass CA, Magnussen A, Hancox JC, Bates DO. VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6. Microcirculation 2008; 15: 605-14.
29. 2+ wave initiation move with caveolae to the trailing edge of migrating cells. J Cell Sci 2002; 115: 475-84.
30. 2+ mobilizing properties in migrating endothelial cells. Am J Physiol Heart Circ Physiol 2001; 281: H745-54.
31. Munaron L, Antoniotti S, Lovisolo D. Intracellular calcium signals and control of cell proliferation: how many mechanisms? J Cell Mol Med 2004; 8: 161-8.
32. 2+]i) in migrating human umbilical vein endothelial cells (HUVECs) stimulated by shear-stress. Life Sci 1999; 65: 2643-51.
33. 2+ signaling in injured in situ endothelium of rat aorta. Cell Calcium 2004; 44: 298-309.
34. Drumheller PD, Hubbell JA. Local modulation of intracellular calcium levels near a single-cell wound in human endothelial monolayers. Arterioscler Thromb 1991; 11: 1258-65.
35. Sammak PJ, Hinman LE, Tran PO, Sjaastad MD, Machen TE. How do injured cells communicate with the surviving cell monolayer? J Cell Sci 1997; 110: 465-75.
36. Hinman LE, Beilman GJ, Groehler KE, Sammak PJ. Woundinduced calcium waves in alveolar type II cells. Am J Physiol 1997; 273: L1242-8.
37. Shabir S, Southgate J. Calcium signalling in wound-responsive normal human urothelial cell monolayers. Cell Calcium 2008; 44: 453-64.
38. 2+ waves in epithelial cells. J Cell Sci 2001; 114: 4185-95.
39. Sung YJ, Sung Z, Ho CL, et al. Intercellular calcium waves mediate preferential cell growth toward the wound edge in polarized hepatic cells. Exp Cell Res 2003; 287: 209-18.
40. Adams DJ, Barakeh J, Laskey R, Van Breemen C. Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 1989; 3: 2389-400.
41. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 2001; 81: 1415-59.
42. Tran QK, Watanabe H. Calcium signalling in the endothelium. Handb Exp Pharmacol 2006; 176: 145-87.
43. Busse R, Fleming I. Vascular endothelium and blood flow. Handb Exp Pharmacol 2006; 176: 43-78.
44. 2+ -regulated secretion of tissue-type plasminogen activator and von Willebrand factor in human endothelial cells. Biochim Biophys Acta 2002; 1600: 162-7.
45. Gautam M, Gojova A, Barakat AI. Flow-activated ion channels in vascular endothelium. Cell Biochem Biophys 2006; 46: 277-84.
46. Kwan HY, Huang Y, Yao X. TRP channels in endothelial function and dysfunction. Biochim Biophys Acta 2007; 1772: 907-14.
47. Yao X, Garland CJ. Recent developments in vascular endothelial cell transient receptor potential channels. Circ Res 2005; 97: 853-63.
48. Mateo J, Miras-Portugal MT, Castro E. Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla. Br J Pharmacol 1996; 119: 1223-32.
49. 2+ signals in primary cultures of cardiac microvascular endothelial cells. Microvasc Res 2001; 61: 240-52.
50. 2+ signals are modulated by ectonucleotidases in in situ endothelial cells of rat aorta. J Vasc Res 2004; 41: 166-73.
51. Usachev YM, Marchenko SM, Sage SO. Cytosolic calcium concentration in resting and stimulated endothelium of excised intact rat aorta. J Physiol 1995; 489: 309-17.
52. 2+ oscillations and STOC activation in endothelial cells. FASEB J 1998; 12: 359-66.
53. 2+ oscillations in microvascular endothelial cells. J Cell Physiol 2003; 194: 139-50.
54. 2+ oscillations in human cerebrovascular endothelial cells after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2009; 29: 57-65.
55. 2+ oscillation frequency regulates agonist-stimulated gene expression in vascular endothelial cells. J Cell Sci 2008; 121: 2511-8.
56. Berridge MJ. Inositol trisphosphate and calcium signalling mechanisms. Biochim Biophys Acta 2009; 1793: 933-40.
57. 2+-ATPase. J Physiol 2000; 524: 701-13.
58. 2+. Pflügers Arch 1996; 432: 614-22.
59. 2+ store in fresh endothelial cells and evidence for ryanodine receptors. Circ Res 1995; 77: 37-42.
60. 2+ signaling in mediating endothelial nitric oxide production in bovine coronary arteries. Am J Physiol Heart Circ Physiol 2006; 290: H1172-81.
61. Long C, Cook LG, Wu GY, Mitchell BM. Removal of FKBP12/12.6 from endothelial ryanodine receptors leads to an in-tracellular calcium leak and endothelial dysfunction. Arterioscler Thromb Vasc Biol 2007; 27: 1580-6.
62. Calcraft PJ, Ruas M, Pan Z, et al. NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature 2009; 459: 596-600.
63. Billington RA, Bellomo EA, Floriddia EM, Erriquez J, Distasi C, Genazzani AA. A transport mechanism for NAADP in a rat basophilic cell line. FASEB J 2006; 20: 521-23.
64. Cioffi DL, Stevens T. Regulation of endothelial cell barrier function by store-operated calcium entry. Microcirculation 2006; 13: 709-23.
65. 2+ channels: impact on cell function. J Physiol 2008; 586: 3043-54.
66. Parekh AB, Putney JW Jr. Store-operated calcium channels. Physiol Rev 2005; 85: 757-810.
67. Trebak M. STIM1/Orai1, ICRAC, and endothelial SOC. Circ Res 2009; 104: e56-7.
68. Pedersen SF, Owsianik G, Nilius B. TRP channels: an overview. Cell Calcium 2005; 38: 233-52.
69. Loot AE, Popp R, Fisslthaler B, Vriens J, Nilius B, Fleming I. Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation. Cardiovasc Res 2008; 80: 445-52.
70. Thodeti CK, Matthews B, Ravi A, et al. TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrinto-integrin signaling. Circ Res 2009; 104: 1123-30.
71. Nilius B, Voets T. TRP channels: a TR(I)P through a world of multifunctional cation channels. Pflügers Arch 2005; 451: 1-10.
72. Smedlund K, Vazquez G. Involvement of native TRPC3 proteins in ATP-dependent expression of VCAM-1 and monocyte adherence in coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 2008; 28: 2049-55.
73. Berridge MJ. Calcium signalling and cell proliferation. Bioessays 1995; 17: 491-500.
74. Born GV, Kratzer MA. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J Physiol 1984; 354: 419-29.
75. Marchenko SM, Sage SO. Electrical properties of resting and acetylcholine-stimulated endothelium in intact rat aorta. J Physiol 1993; 462: 735-51.
76. Antoniotti S, Fiorio Pla A, Pregnolato S, Mottola A, Lovisolo D, Munaron L. Control of endothelial cell proliferation by calcium in-flux and arachidonic acid metabolism: a pharmacological approach. J Cell Physiol 2004; 197: 370-8.
77. 2+ entry is involved in early steps of tumor angiogenesis. Mol Cancer Res 2008; 6: 535-45.
78. 2+-dependent signal transduction. Traffic 2003; 4: 717-23.
79. Cooke JP. NO and angiogenesis. Atheroscler Suppl 2003; 4: 53-60.
80. Erdogan A, Schaefer CA, Schaefer M, et al. Margatoxin inhibits VEGF-induced hyperpolarization, proliferation and nitric oxide production of human endothelial cells. J Vasc Res 2005; 42: 368-76.
81. Kahl CR, Means AR. Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 2003; 24: 719-36.
82. 2+]i) in migrating human umbilical vein endothelial cells (HUVECs) stimulated by shear-stress. Life Sci 1999; 65: 2643-51
83. 2+ influxand phosphatidylinositol 3-kinase-mediated m-calpain activity for shear stress-induced endothelial cell polarity. Am J Physiol Cell Physiol 2007; 293: C1216-25.
84. Zheng JQ, Poo MM. Calcium signaling in neuronal motility. Annu Rev Cell Dev Biol 2007; 23: 375-404.
85. Moccia F, Berra-Romani R, Baruffi S, et al. Basal nonselective cation permeability in rat cardiac microvascular endothelial cells. Microvasc Res 2002; 64: 187-97.
86. 2+ uptake in bovine vascular endothelial cells. J Physiol 2002; 539: 77-91.
87. Contreras JE, Sánchez HA, Véliz LP, Bukauskas FF, Bennett MV, Sáez JC. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res Brain Res Rev 2004; 47: 290-303.
88. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 2002; 22: 364-73.
89. 2+ channels and T-lymphocyte activation by the pyrazole derivative BTP2. J Biol Chem 2004; 279: 12427-37.
90. Ramsey IS, Delling M, Clapham DE. An introduction to TRP channels. Annu Rev Physiol 2006; 68: 619-47.
91. Burghardt RC, Barhoumi R, Sewall TC, Bowen JA. Cyclic AMP induces rapid increases in gap junction permeability and changes in the cellular distribution of connexin43. J Membr Biol 1995; 148: 243-53.
92. el-Sabban ME, Pauli BU. Cytoplasmic dye transfer between metastatic tumor cells and vascular endothelium. J Cell Biol 1991; 115: 1375-82.
93. Ryan MJ, Liu B, Herbowy MT, Gross KW, Hajduczok G. Intercellular communication between renin expressing As4.1 cells, endothelial cells and smooth muscle cells. Life Sci 2003; 72: 1289-301.
94. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol 2003; 4: 285-94.
95. Brisset AC, Isakson BE, Kwak BR. Connexins in vascular physiology and pathology. Antioxid Redox Signal 2009; 11: 267-82.
96. de Wit C, Hoepfl B, Wölfle SE. Endothelial mediators and communication through vascular gap junctions. Biol Chem 2006; 387: 3-9.
97. Figueroa XF, Isakson BE, Duling BR. Connexins: gaps in our knowledge of vascular function. Physiology 2004; 19: 277-84.
98. Haefliger JA, Nicod P, Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc Res 2004; 62: 345-56.
99. Morel S, Burnier L, Kwak BR. Connexins participate in the initiation and progression of atherosclerosis. Semin Immunopathol 2009; 31: 49-61.
100. Scemes E, Spray DC, Meda P. Connexins, pannexins, innexins: novel roles of hemi-channels. Pflugers Arch 2009; 457: 1207-26.
101. Sáez JC, Retamal MA, Basilio D, Bukauskas FF, Bennett MV. Connexin-based gap junction hemichannels: gating mechanisms. Biochim Biophys Acta 2005; 1711: 215-24.
102. Stout C, Goodenough DA, Paul DL. Connexins: functions without junctions. Curr Opin Cell Biol 2004; 16: 507-12.
103. Oyamada M, Oyamada Y, Takamatsu T. Regulation of connexin expression. Biochim Biophys Acta 2005; 1719: 6-23.
104. Okamoto T, Akiyama M, Takeda M, Gabazza EC, Hayashi T, Suzuki K. Connexin32 is expressed in vascular endothelial cells and participates in gap-junction intercellular communication. Biochem Biophys Res Commun 2009; 382: 264-8.
105. Gabriels JE, Paul DL. Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ Res 1998; 83:636-43.
106. Ebihara L. New roles for connexons. News Physiol Sci 2003; 18: 100-3.
107. Faigle M, Seessle J, Zug S, El Kasmi KC, Eltzschig HK. ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS One 2008; 3: e2801.
108. Gomes P, Srinivas SP, Van Driessche W, Vereecke J, Himpens B. ATP release through connexin hemichannels in corneal endothelial cells. Invest Ophthalmol Vis Sci 2005; 46: 1208-18.
109. Braet K, Aspeslagh S, Vandamme W, et al. Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells. J Cell Physiol 2003; 19: 205-13.
110. Hervé JC, Sarrouilhe D. Connexin-made channels as pharmacological targets. Curr Pharm Des 2005; 11: 1941-58.
111. Shintani-Ishida K, Uemura K, Yoshida K. Hemichannels in cardiomyocytes open transiently during ischemia and contribute to reperfusion injury following brief ischemia. Am J Physiol Heart Circ Physiol 2007; 293: H1714-20.
112. Bukauskas FF, Verselis VK. Gap junction channel gating. Biochim Biophys Acta 2004; 1662: 42-60.
113. Schalper KA, Palacios-Prado N, Orellana JA, Sáez JC. Currently used methods for identification and characterization of hemichannels. Cell Commun Adhes 2008; 15: 207-18.
114. Thompson RJ, Macvicar BA. Connexin and pannexin hemichannels of neurons and astrocytes. Channels (Austin) 2008; 2: 81-86.
115. Iglesias R, Dahl G, Qiu F, Spray DC, Scemes E. Pannexin 1: the molecular substrate of astrocyte hemichannels. J Neurosci 2009; 29: 7092-7.
116. Burnier L, Fontana P, Angelillo-Scherrer A, Kwak BR. Intercellular communication in atherosclerosis. Physiology (Bethesda) 2009; 24: 36-44.
117. Yeh HI, Lai YJ, Chang HM, Ko YS, Severs NJ, Tsai CH. Multiple connexin expression in regenerating arterial endothelial gap junctions. Arterioscler Thromb Vasc Biol 2000; 20: 1753-62.
118. Kwak BR, Pepper MS, Gros DB, Meda P. Inhibition of endothelial wound repair by dominant negative connexin inhibitors. Mol Biol Cell 2001; 12: 831-45.
119. Pepper MS, Montesano R, el Aoumari A, Gros D, Orci L, Meda P. Coupling and connexin 43 expression in microvascular and large vessel endothelial cells. Am J Physiol 1992; 262: C1246-57.
120. Chadjichristos CE, Matter CM, Roth I. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 2006; 113: 2835-43.
121. Wang HH, Kung CI, Tseng YY, et al. Activation of endothelial cells to pathological status by down-regulation of connexin43. Cardiovasc Res 2008; 79: 509-18.
122. Wong CW, Christen T, Roth I, et al. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 2006; 12: 950-4.
123. Evans WH, Leybaert L. Mimetic peptides as blockers of connexin channel-facilitated intercellular communication. Cell Commun Adhes 2007; 14: 265-73.
124. Yeh HI, Lu SK, Tian TY, Hong RC, Lee WH, Tsai CH. Comparison of endothelial cells grown on different stent materials. Biomed Mater Res Part A 2006; 76: 835-41.
125. Dhein S, Weng S, Grover R, et al. Protein kinase C mediates the effect of antiarrhythmic peptide on gap junction conductance. Cell Commun Adhes 2001; 8: 257-64.
126. Salameh A, Dhein S. Pharmacology of Gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer? Biochim Biophys Acta 2005; 1719: 36-58.
127. Dhein S. Pharmacology of gap junctions in the cardiovascular system. Cardiovasc Res 2004; 62: 287-98.
128. Lang NN, Myles RC, Burton FL. The vascular effects of rotigaptide in vivo in man. Biochem Pharmacol 2008; 76: 1194-200.
129. Takahashi H, Letourneur D, Grainger DW. Delivery of large biopharmaceuticals from cardiovascular stents: a review. Biomacromolecules 2007; 8: 3281-93.
130. O'Carroll SJ, Alkadhi M, Nicholson LF, Green CR. Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury. Cell Commun Adhes 2008; 15: 27-42.